hydralazine has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Excerpt | Relevance | Reference |
---|---|---|
"Hydralazine treatment further resulted in the accumulation of reactive oxygen species, whereas a superoxide dismutase mimetic inhibited hydralazine-induced cell death." | 1.43 | The antihypertensive drug hydralazine activates the intrinsic pathway of apoptosis and causes DNA damage in leukemic T cells. ( Campillo-Davo, D; Lucendo, E; Martínez-Aguilar, R; Ruiz-Magaña, MJ; Ruiz-Ruiz, C; Schulze-Osthoff, K, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ruiz-Magaña, MJ | 1 |
Martínez-Aguilar, R | 1 |
Lucendo, E | 1 |
Campillo-Davo, D | 1 |
Schulze-Osthoff, K | 1 |
Ruiz-Ruiz, C | 1 |
1 other study available for hydralazine and Leukemia, Lymphoblastic, Acute, T Cell
Article | Year |
---|---|
The antihypertensive drug hydralazine activates the intrinsic pathway of apoptosis and causes DNA damage in leukemic T cells.
Topics: Antihypertensive Agents; Antineoplastic Agents; Apoptosis; DNA Damage; Humans; Hydralazine; Jurkat C | 2016 |